Sagent Pharmaceuticals (NASDAQ:SGNT) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research report issued on Thursday, AnalystRatings.Net reports. The firm currently has a $25.90 price target on the stock. Zacks‘ price target indicates a potential upside of 6.67% from the company’s current price. Sagent Pharmaceuticals Inc (NASDAQ:SGNT) shares closed at $20.03 on last trade day, by losing -0.99%. Stock 52 week range is $13.39 – $26.08. Company’s market capitalization is $318.86 billion.
Organovo Holdings Inc (NYSEMKT:ONVO) CEO, Keith Murphy sold 100,000 shares of the stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $10.86, for a total value of $1,086,000.00. Following the completion of the sale, the chief executive officer now directly owns 6,101,748 shares of the company’s stock, valued at approximately $66,264,983. Organovo Holdings Inc (NYSEMKT:ONVO) stock decreased -7.51% and finished the last session at $9.12. The EPS of the stock remained -0.63. Company’s market capitalization is $704.78 billion.
Hill-Rom Holdings, Inc. (NYSE:HRC) had its target price cut by Piper Jaffray from $44.00 to $40.00. They currently have a neutral rating on the stock. Hill-Rom Holdings, Inc. (NYSE:HRC) stock opened at $0.25 in last trading session and closed at $37.05. The 52 week range of the stock is $31.71 – $44.64 and the day range was $36.15 – %37.45.
Leave a Reply